If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]
Several major biotech companies like Biogen (BIIB – Analyst Report), AbbVie (ABBV – Analyst Report), Celgene and Gilead reported second quarter results over the last five trading days. Biogen has been grabbing headlines for the wrong reasons – although the company’s earnings were better-than-expected, revenues missed expectations.With the company saying that it is cutting its outlook based on revised expectations […]
By Johanna BennettDo you want safe, or sexy?That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results.“In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note.After shrugging off a selloff in late June, the Nasdaq Biotechnology index has gained 30% since […]
By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]
ShutterstockNEW YORK (MarketWatch)—Biotech stocks slumped Monday, with the largest biotech ETF down about 1.7% and on track to snap an eight-session winning streak.The slide comes as some market watchers warn that biotech shares have enjoyed a great run-up and could be due for a drop.“Biotech must be slaughtered” is how a post over at the iBankCoin blog puts it.How low […]
By Ben LevisohnRBC’s Michael Yee and team explain why Celgene (CELG), Biogen Idec (BIIB), Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN) and Regeneron Pharmaceuticals (REGN) are their top biotech stocks for 2015:
Bloomberg News
Top-five longs: Celgene, Biogen Idec, BioMarin Pharmaceutical, Vertex Pharmaceuticals, Regeneron Pharmaceuticals: 1) Celgene we predict “settlement” with Actavis (ACT) could happen after spring when expert discovery ends and before Court begins mid-15; plus investors should start giving […]
By Ben LevisohnLeerink’s Howard Liang and team think 2015 will be another good year for biotech stocks like Gilead Sciences (GILD), Celgene (CELG), Amgen (AMGN ) and Alexion Pharmaceuticals (ALXN). They explain why:
Boston Globe via Getty Images
Biotech fundamentals appear strong, and could attract and broaden investor interest in the sector. Ongoing and upcoming product launches could be among the fastest […]
moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]
moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]
moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]
